{
  "labels": {
    "done": "完成",
    "current": "现在",
    "planned": "计划",
    "tentative": "待定",

    "diagnosis": "诊断",
    "chemotherapy": "化疗",
    "radiotherapy": "放疗",
    "transplant": "移植",
    "rehab": "康复",
    "event": "事件",
    "surgery": "手术",
    "other": "其他"
  },
  "ui": {
    "page_title": "医疗时间轴",
    "meta_updated": "已更新",
    "legend_done": "完成 — 已完成的阶段/事件",
    "legend_now": "现在 — 当前阶段",
    "legend_planned": "计划 — 已安排/预计",
    "legend_tentative": "待定 — 可能，未确认",
    "section_completed": "已完成",
    "section_now": "现在",
    "section_plans": "计划",
    "no_entries": "暂时没有记录。",
    "btn_details": "详情",
    "btn_hide": "收起",
    "confidence": "置信度",
    "notice_tbd": "“TBD” = “待确定”（日期/细节尚未确定）。本图仅供参考，不构成医疗建议。"
  },
  "items": {
    "2019-01-dx-staging": {
      "when_label": "一月–三月 2019",
      "title": "初始诊断——T 淋巴母细胞性淋巴瘤；分期",
      "summary": "初步检查确认 T 淋巴母细胞性淋巴瘤；完成基线检测与分期。",
      "details": "血液科会诊、影像与活检确立诊断与分期。治疗前记录心脏与实验室基线。"
    },
    "2019-03-first-chemo-rt": {
      "when_label": "三月–八月 2019",
      "title": "针对淋巴瘤的化疗（T 淋巴母细胞性）",
      "summary": "系统性化疗及支持治疗；辅助放疗。",
      "details": "按计划进行周期治疗并进行中期与结疗评估。巩固性放疗约 30 次。"
    },
    "2020-04-relapse-dx": {
      "when_label": "四月 2020",
      "title": "复发——T 淋巴母细胞性淋巴瘤（诊断）",
      "summary": "确认复发；更新治疗方案。",
      "details": "诊断性复评再次确认 T 淋巴母细胞性淋巴瘤；指征为重启系统治疗。"
    },
    "2020-04-11-chemo-rt-mi": {
      "when_label": "四月–十一月 2020",
      "title": "化疗并行放疗 ×30；严重消化道出血并心肌梗死",
      "summary": "化疗与放疗恢复；消化性溃疡出血导致心梗；稳定后继续治疗。",
      "details": "重度贫血与心动过速以输血和重症监护处理。放疗与化疗并行：约 30 次。"
    },
    "2021-05-aggressive-leukocytosis-dx": {
      "when_label": "五月 2021",
      "title": "侵袭性白血病伴极端白细胞增多——诊断",
      "summary": "白细胞 >30 万；确立诊断；启动细胞减少治疗。",
      "details": "白血病进展迅速（后证实有 Ph+ 特征）；需紧急细胞减少与输血支持。"
    },
    "2021-05-2023-09-chemo-aggr-leukemia": {
      "when_label": "五月 2021–九月 2023",
      "title": "针对侵袭性白血病的化疗",
      "summary": "长期系统化疗以达到 CAR-T 适应与病情控制。",
      "details": "逐步强化/调整方案，将白细胞降至 CAR-T 阈值以下；并行处理感染。"
    },
    "2022-03-26-neuro-shock": {
      "when_label": "三月–四月 2022",
      "title": "全身性休克并瘫痪、记忆丧失",
      "summary": "抢救复苏；长期神经缺损，逐步恢复。",
      "details": "急性崩溃需心肺复苏。其后出现瘫痪、遗忘与认知迟缓；在神经科指导下逐步恢复。"
    },
    "2022-10-invasive-fungal-sepsis": {
      "when_label": "十月 2022",
      "title": "侵袭性真菌感染并败血症",
      "summary": "严重口咽部病灶并全身受累；治疗成功。",
      "details": "住院行抗感染治疗；并有心律失常及 2022 年的微卒中病史。"
    },
    "2022-12-covid-icu-gi-bleed": {
      "when_label": "十二月 2022–一月 2023",
      "title": "新冠肺炎（重症监护、气管插管）与胃肠道出血；康复",
      "summary": "重症新冠需插管；并发 GI 出血与昏迷；后意外康复。",
      "details": "在免疫抑制下肺炎迅速进展；重症后逐步恢复并稳定。"
    },
    "2023-06-respiratory-arrest-sepsis": {
      "when_label": "六月–九月 2023",
      "title": "呼吸停止（复苏）与菌血症；高剂量化疗",
      "summary": "心肺事件逆转；心源性菌血症治疗；为达 CAR-T 标准而强化化疗。",
      "details": "升级治疗以降白至 CAR-T 阈值以下；并发感染得到控制。"
    },
    "2023-10-car-t": {
      "when_label": "十月–十一月 2023",
      "title": "CAR-T 细胞治疗",
      "summary": "完成 CAR-T；严重毒性（发热、神经与心脏事件）得到控制。",
      "details": "高热、呕吐、下肢短暂瘫痪、心脏事件与显著记忆丧失；随后逐步恢复。"
    },
    "2024-01-allo-sct-brother-bradonor": {
      "when_label": "一月 2024",
      "title": "同种异体造血干细胞输注——兄长供者",
      "summary": "CAR-T 后的巩固性同种异体干细胞输注。",
      "details": "植入期在严格感染控制下进行；随后门诊恢复。"
    },
    "2024-07-abdominal-mass-hl": {
      "when_label": "七月 2024",
      "title": "腹部巨大肿块；侵袭性霍奇金淋巴瘤",
      "summary": "确诊新发 HL，与既往疾病不同；治疗方案调整。",
      "details": "可能与既往治疗背景相关；肿瘤科提出新的化疗策略。"
    },
    "2024-08-2025-06-chemo-rt": {
      "when_label": "八月 2024–六月 2025",
      "title": "强化化疗 → 败血症并发症 → 切换至有效方案；放疗 ×30",
      "summary": "起始大剂量致败血症；改用更耐受且有效的方案；辅以放疗（30 次）。",
      "details": "败血症后调整方案；后续疗程见效。追加巩固性放疗（30 天次）。"
    },
    "2024-10-nasal-fracture-rhinoplasty": {
      "when_label": "十月–十一月 2024",
      "title": "严重鼻骨骨折；外科鼻整形术",
      "summary": "跌倒致粉碎性鼻骨骨折 → 持续性流鼻血与呼吸受阻；十一月行根治性手术。",
      "details": "2024 年十月下旬发生外伤性跌倒，致多段鼻骨骨折。持续性鼻出血与气道受阻使自愈不可能；十一月行重建性鼻整形，复位骨骼并修复软组织。症状亦使高强度化疗更难耐受，直至手术缓解阻塞。"
    },
    "2025-06-relapse-Ph-pos": {
      "when_label": "六月下旬 2025",
      "title": "白细胞上升；检测到 Ph+ 淋巴系细胞",
      "summary": "白细胞数在数日内由约 3.5 万升至约 6.7 万；确认 Ph+ 淋巴谱系。",
      "details": "肿瘤科建议先行口服化疗，稳定后启动酪氨酸激酶抑制剂（ponatinib）。"
    },
    "2025-07-oral-chemo-14": {
      "when_label": "七月 2025 – 现在",
      "title": "口服多药化疗（14 次）",
      "summary": "在家口服的结构化方案，共 14 次剂量。",
      "details": "复杂的口服联合，用于中期化验与耐受性监测；疗程结束后设定决策点。"
    },
    "plan-2025-support-recovery": {
      "when_label": "化疗后（TBD）",
      "title": "支持与功能恢复",
      "summary": "当前疗程后进行结构化的支持照护与康复。",
      "details": "将依据化疗后状态与实验室动态调整范围与时间表."
    },
    "plan-2025-tki-lifelong": {
      "when_label": "病情稳定后（TBD）",
      "title": "酪氨酸激酶抑制剂（ponatinib）— 长期",
      "summary": "细胞减少后启动 TKI 维持；可能为长期/终身。",
      "details": "在血液学控制可接受后开始；监测疗效与不良反应；预计进行剂量优化。"
    },
    "plan-2025-re-irradiation": {
      "when_label": "如需（TBD）",
      "title": "可能的再次放疗",
      "summary": "若疾病控制需要，可考虑再次放疗。",
      "details": "由肿瘤多学科团队（tumor board）讨论；取决于影像与既往照射剂量。"
    },
    "plan-2025-chemo-switch": {
      "when_label": "若当前方案效果不足（TBD）",
      "title": "可能更换当前化疗方案",
      "summary": "根据疗效或毒性，可能需要切换方案。",
      "details": "在重新评估化验、影像与耐受性后决定；必要时选用替代方案。"
    },
    "plan-2025-next-line-chemo": {
      "when_label": "如有需要（TBD）",
      "title": "可能的下一线化疗",
      "summary": "视病情动态，可能需要进一步化疗。",
      "details": "由肿瘤多学科团队在评估当前疗程后确定。"
    },
    "plan-2026-repeat-allo-sct": {
      "when_label": "2026（可能）",
      "title": "可能再次进行同种异体干细胞移植",
      "summary": "若病程需要最终巩固，可作为一种选择。",
      "details": "取决于对 TKI 与化疗的反应；需评估供者/中心并权衡风险与收益。"
    }
  }
}
